Clinical Trials Directory

Trials / Completed

CompletedNCT01726491

Epigenetics and the Origin of Muscle Insulin Resistance in Humans

Status
Completed
Phase
Study type
Observational
Enrollment
46 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Accepted

Summary

The investigators are trying to understand the role of DNA (deoxyribonucleic acid) methylation in insulin resistance in skeletal muscle and blood tissues. DNA methylation is a normal chemical process in the body that modifies DNA. By studying this, the investigators hope to better understand the causes of insulin resistance.

Detailed description

Insulin resistance is defined as the decreased ability of insulin to perform its biological function in the muscle, liver and fat. Genetic and environmental factors are known to influence insulin sensitivity. It is not known how this is mediated. This study looks at the role of epigenetics (modifications of proteins associated with DNA and methylation of DNA) in alterations in insulin resistance. We will study lean healthy people, obese non-diabetic people and people with type 2 diabetes to characterize the DNA methylation patterns in muscle in each group. The second aim of the study is to see how a single bout of exercise affects the DNA methylation in the muscle. The third aim looks at the effect of 8 weeks of supervised exercise on the DNA methylation.

Conditions

Timeline

Start date
2012-08-01
Primary completion
2016-11-21
Completion
2016-11-21
First posted
2012-11-15
Last updated
2018-01-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01726491. Inclusion in this directory is not an endorsement.

Epigenetics and the Origin of Muscle Insulin Resistance in Humans (NCT01726491) · Clinical Trials Directory